share_log

微創醫療：股份發行人截至二零二四年三月三十一日的證券變動月報表

MICROPORT: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024

香港交易所 ·  Apr 8 05:33
Summary by Moomoo AI
微創醫療科學有限公司於2024年4月8日向香港交易及結算所有限公司提交了最新的證券變動月報表，報告截至2024年3月31日的公司股本變動情況。報告顯示，公司的法定/註冊股本及已發行股份在報告期內維持不變，普通股股份數目仍為5,000,000,000股，每股面值0.00001美元，法定/註冊股本總額為50,000美元。此外，公司的股份期權計劃中，購股權計劃的股份期權數目有所變動，其中一項計劃於本月內註銷了608,629股份期權，導致本月底結存的股份期權數目為72,255,339股。公司還披露了兩項可換股票據的詳情，包括2026年到期的零息可換股債券和2028年到期的5.75%可換股債券，兩者的已發行總額分別為448,000,000美元和220,000,000美元。報告最後確認，所有證券的發行均已獲得董事會授權，並符合香港聯合交易所有限公司證券上市規則的相關要求。
微創醫療科學有限公司於2024年4月8日向香港交易及結算所有限公司提交了最新的證券變動月報表，報告截至2024年3月31日的公司股本變動情況。報告顯示，公司的法定/註冊股本及已發行股份在報告期內維持不變，普通股股份數目仍為5,000,000,000股，每股面值0.00001美元，法定/註冊股本總額為50,000美元。此外，公司的股份期權計劃中，購股權計劃的股份期權數目有所變動，其中一項計劃於本月內註銷了608,629股份期權，導致本月底結存的股份期權數目為72,255,339股。公司還披露了兩項可換股票據的詳情，包括2026年到期的零息可換股債券和2028年到期的5.75%可換股債券，兩者的已發行總額分別為448,000,000美元和220,000,000美元。報告最後確認，所有證券的發行均已獲得董事會授權，並符合香港聯合交易所有限公司證券上市規則的相關要求。
Micro-Chung Medical Sciences Limited filed with Hong Kong Trading and Settlement Limited on 8 April 2024 with Hong Kong Trading and Settlement Holdings Limited, reporting the changes in the company's share capital as of 31 March 2024. The report shows that the company's regulary/registered share capital and issued shares remained unchanged during the reporting period, with the number of ordinary shares remaining at 5,000,000,000 shares with a face value of $0.00001 per share and a total regulated/registered share capital of $50,000. In addition, the number of share options under the Company's stock option plan has changed, with one of which 608,629 share options were written off during the month, resulting in 72,255,339 shares outstanding at the end of the month. THE COMPANY ALSO...Show More
Micro-Chung Medical Sciences Limited filed with Hong Kong Trading and Settlement Limited on 8 April 2024 with Hong Kong Trading and Settlement Holdings Limited, reporting the changes in the company's share capital as of 31 March 2024. The report shows that the company's regulary/registered share capital and issued shares remained unchanged during the reporting period, with the number of ordinary shares remaining at 5,000,000,000 shares with a face value of $0.00001 per share and a total regulated/registered share capital of $50,000. In addition, the number of share options under the Company's stock option plan has changed, with one of which 608,629 share options were written off during the month, resulting in 72,255,339 shares outstanding at the end of the month. THE COMPANY ALSO DISCLOSED DETAILS OF TWO CONVERTIBLE STOCK NOTES, INCLUDING ZERO-YIELD CONVERTIBLE NOTES DUE 2026 AND 5.75% CONVERTIBLE NOTES DUE 2028, WHICH HAVE A TOTAL ISSUED AMOUNT OF $448,000,000 AND $220,000,000, RESPECTIVELY. The report finally confirms that all issuance of securities has been authorised by the Board of Directors and complies with the relevant requirements of the Securities Listing Rules of the Hong Kong Stock Exchange Limited.

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more